Will Travere’s Removal From Key Russell Value Indices Change Travere Therapeutics' (TVTX) Narrative?
In late June 2026, Travere Therapeutics, Inc. was removed from several major Russell value and small-cap benchmarks, including the Russell 2000 Value, Russell 3000 Value, Russell 2500 Value, Russell Small Cap Comp Value, and Russell 3000E Value indices. This broad index removal can prompt forced portfolio rebalancing by index-tracking funds, potentially shifting how institutional investors assess Travere’s role in diversified healthcare portfolios. We’ll now examine how Travere’s removal...
What's Your Reaction?











